Invizius
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $11M
Investors
- 6
About Invizius
Based in Scotland, Invizius Ltd develops innovative complement therapeutics, focusing on treatments for autoimmune and inflammatory disorders.Invizius Ltd, founded in 2017 in Motherwell, UK, specializes in developing second-generation complement therapeutics.Invizius specializes in the development of second-generation complement therapeutics specifically designed to address autoimmune and inflammatory disorders. The company's lead product, H-Guard, is currently in clinical development and aims to meet significant unmet medical needs for patients undergoing dialysis and other extracorporeal circuit therapies. This proprietary technology enhances natural complement regulators, thereby maximizing patient safety and clinical efficacy. Invizius primarily targets the healthcare sector, serving hospitals and medical facilities where patients require advanced treatment for inflammatory and fibrotic conditions.Invizius's revenue model is expected to revolve around partnerships with healthcare providers and procurement through hospital systems, focusing on direct-to-consumer sales within regulated environments. The company engages in B2B transactions, collaborating with healthcare institutions to integrate their products into treatment protocols. H-Guard, as a flagship product, is positioned for distribution through specialized medical supply channels, where providers may procure the therapy for their patients. Revenue generation will primarily depend on the successful completion of clinical trials and securing necessary regulatory approvals, which are critical to determining the terms of sales agreements with healthcare organizations. The company aims to expand its market presence, targeting North America, Europe, and Asia as potential regions for growth based on regulatory approval timelines and the outcomes of clinical trials.
Who invested in Invizius
6 investors across 2 rounds
See all investors in Invizius
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Invizius
Who invested in Invizius?
Invizius has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Invizius raised?
Invizius has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Invizius last raise money?
Invizius's most recent round on record is a Series A, in Mar 2021.
What does Invizius do?
Based in Scotland, Invizius Ltd develops innovative complement therapeutics, focusing on treatments for autoimmune and inflammatory disorders.
Where is Invizius headquartered?
Invizius is headquartered in Motherwell, UK.
Which VCs invest in companies like Invizius?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Invizius's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Invizius? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.